siRNA, Anti-MARK3, 2'-OMe/LNA/Ribo/Backbone-modified(CAT#: SIRGT11692WQ-2OMe)

The product SIRGT11692WQ-2OMe is a type of small interfering RNA (siRNA) that targets MARK3 gene and regulates the expression of gene. The siRNA interferes with the expression of MARK3 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_001128918.2; NM_001128919.2; NM_001128920.2; NM_001128921.2; NM_002376.6
Alternative Names CTAK1; KP78; PAR1A; Par-1a
Related Diseases Brain Stem Astrocytic Neoplasm
Purification HPLC
Target Gene
Gene ID 4140
Uniprot ID P27448
Sub Cat Target Species Modification Scale  
SIRGT14692WQ-LNA MARK3 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT11692WQ-RB MARK3 Human Ribo-modified Inquiry
SIRGT12692WQ-BB MARK3 Human Backbone-modified Inquiry

Related Products